We are live on ! Find out more
SCM

Scopia Capital Management Portfolio holdings

AUM $146M
1-Year Est. Return 25.93%
This Fund
S&P 500
This Quarter Est. Return
+22.57%
1 Year Est. Return
+25.93%
3 Year Est. Return
+30.87%
5 Year Est. Return
+45.28%
10 Year Est. Return
+379.83%
AUM
$2.71B
AUM Growth
-$240M
Cap. Flow
-$755M
Cap. Flow %
-27.88%
Top 10 Hldgs %
74.71%
Holding
35
New
7
Increased
3
Reduced
14
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 26.43%
2 Industrials 18.38%
3 Utilities 12.72%
4 Consumer Discretionary 10.02%
5 Technology 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VST icon
1
Vistra
VST
$48.3B
$344M 12.72%
13,230,577
-142,941
-1% -$3.61M
JCI icon
2
Johnson Controls International
JCI
$83.7B
$255M 9.41%
6,893,643
-1,140,769
-14% -$39.1M
JD icon
3
JD.com
JD
$43.3B
$217M 8.03%
7,207,601
-443,672
-6% -$11.3M
ITRI icon
4
Itron
ITRI
$4.48B
$216M 7.97%
4,624,932
-461,600
-9% -$24.5M
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$216M 7.97%
8,159,184
-2,566,458
-24% -$60.8M
SPR
6
DELISTED
Spirit AeroSystems
SPR
$209M 7.71%
2,280,283
-2,365,467
-51% -$209M
ETRN
7
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$182M 6.71%
8,343,608
+1,256,715
+18% +$25.2M
SPY icon
8
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$776B
$153M 5.66%
+542,100
New +$147M
GWPH
9
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$126M 4.67%
749,538
-595,660
-44% -$88.6M
ZGNX
10
DELISTED
Zogenix, Inc.
ZGNX
$105M 3.88%
1,910,753
-1,075,081
-36% -$51.2M
SRC
11
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$103M 3.79%
2,583,473
+627,017
+32% +$23.9M
TVTX icon
12
Travere Therapeutics
TVTX
$5.13B
$95.4M 3.52%
4,214,972
-1,695,881
-29% -$37.5M
VG
13
DELISTED
Vonage Holdings Corporation
VG
$87M 3.21%
+8,664,115
New +$83.2M
ISBC
14
DELISTED
Investors Bancorp, Inc.
ISBC
$85.6M 3.16%
7,224,672
-3,609,152
-33% -$43.5M
PTCT icon
15
PTC Therapeutics
PTCT
$6.13B
$79.3M 2.93%
2,106,190
+479,225
+29% +$16.1M
ACOR
16
DELISTED
Acorda Therapeutics
ACOR
$59.3M 2.19%
37,167
-8,592
-19% -$15.5M
OPLN
17
Openlane
OPLN
$4.31B
$54M 1.99%
+2,779,104
New +$52.4M
IMMU
18
DELISTED
Immunomedics Inc
IMMU
$37.2M 1.38%
+1,937,843
New +$31.2M
WBT
19
DELISTED
Welbilt, Inc.
WBT
$33.9M 1.25%
+2,069,997
New +$30.2M
YMAB
20
DELISTED
Y-mAbs Therapeutics
YMAB
$24.1M 0.89%
920,282
-667,284
-42% -$14.7M
HLIT icon
21
Harmonic Inc
HLIT
$1.14B
$15.6M 0.58%
+2,877,593
New +$15.3M
PRTA icon
22
Prothena Corp
PRTA
$443M
$7.28M 0.27%
600,000
-4,018,164
-87% -$50.2M
LJPC
23
DELISTED
La Jolla Pharmaceutical Company
LJPC
$3.09M 0.11%
480,000
-1,907,336
-80% -$12.4M
AMSC icon
24
American Superconductor
AMSC
$1.28B
$252K 0.01%
+19,610
New +$267K
AYI icon
25
Acuity Brands
AYI
$9.86B
-185,930
Closed -$21.4M

Similar funds

Scopia Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Scopia Capital Management held 35 positions worth $2.71B, down 8.1% from $2.95B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Scopia Capital Management withdrew a net $755M in Q1 2019, closing 11 positions and reducing 14 holdings. Its most notable exit was NXP Semiconductors, an estimated $129M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Industrials and Utilities.

Against the trend, Scopia Capital Management opened a new position in Vonage Holdings Corporation worth $87M.

  • Scopia Capital Management's largest Q1 2019 buy was Vonage Holdings Corporation: 8,664,115 shares worth $87M.
  • Scopia Capital Management added most to Equitrans Midstream Corporation Common Stock in Q1 2019, an estimated $25.2M increase.
  • Scopia Capital Management's biggest Q1 2019 reduction was Spirit AeroSystems, cutting an estimated $209M.
  • Scopia Capital Management fully exited NXP Semiconductors in Q1 2019, selling an estimated $129M.
  • Scopia Capital Management's ten largest holdings make up 75% of its $2.71B portfolio in Q1 2019.
  • Scopia Capital Management opened 7 new positions and closed 11 in Q1 2019.
  • Scopia Capital Management's portfolio value fell 8.1% quarter-over-quarter to $2.71B.

Based on Scopia Capital Management's 13F filing for Q1 2019, filed 15 May 2019.